News

Dianthus Therapeutics Welcomes Dr. Simon Read to Its Board

Dianthus Therapeutics Welcomes Dr. Simon Read to Its Board

Dr. Simon Read Joins Dianthus Therapeutics Board

Dr. Simon Read has been appointed to the Board of Directors of Dianthus Therapeutics, Inc. This decision comes as the company continues to pave the way in developing antibody complement therapeutics aimed at treating severe autoimmune diseases.

Expertise in Biopharmaceuticals

With over 30 years in the biopharmaceutical industry, Dr. Read brings a wealth of knowledge and leadership experience. He is known for his success as the CEO and Founder of Mariana Oncology and served as the Chief Scientific Officer at Ra Pharma. His leadership has driven significant advancements and innovations in drug development.

Transition on the Board

Alongside Dr. Read's exciting appointment, Lonnie Moulder will be stepping away from his role on the Board of Directors. Alison Lawton, Chair of Dianthus, expressed her gratitude for Moulder's contributions, citing his vital support during the company's rapid growth from a private to a publicly traded entity.

Recognizing Contributions and Looking Ahead

Lonnie Moulder highlighted the impressive progress Dianthus has made, particularly in advancing its complement inhibitors since initial investments started in 2019. His optimism for Dianthus' future underscores a strong foundation that supports ongoing clinical trials.

Dr. Read's Background

Before joining Dianthus, Dr. Read's career featured significant roles at GlaxoSmithKline, AstraZeneca, and Roche/Genentech. He was instrumental in the clinical development of prominent immunology drugs, which contributes to his expertise today.

Commitment to Innovation

In his new position, Dr. Read expressed enthusiasm about collaborating with the Dianthus team, especially concerning the forthcoming Phase 2 MaGic trial results expected soon. He believes DNTH103 holds the potential to become a groundbreaking therapy for patients with severe neuromuscular disorders.

About Dianthus Therapeutics

Dianthus Therapeutics stands at the forefront of biopharmaceutical innovation, focusing on the design and delivery of cutting-edge monoclonal antibodies. The company operates from its bases in New York City and Waltham, aiming to create transformative therapies for patients battling severe autoimmune and inflammatory diseases.

Company Vision and Future Goals

With a dedicated team of industry veterans, Dianthus continues to make strides in research and development, bolstered by a commitment to creating therapies that significantly improve patient outcomes.

Contact Information

For further inquiries, please reach out to:

Jennifer Davis Ruff
Dianthus Therapeutics
jdavisruff@dianthustx.com

Frequently Asked Questions

Who is Dr. Simon Read?

Dr. Simon Read is a biopharmaceutical expert with over 30 years of experience and has been appointed to Dianthus Therapeutics' Board of Directors.

What role did Lonnie Moulder play at Dianthus?

Lonnie Moulder served on the Board of Directors and played a crucial role in guiding Dianthus' growth from a private entity to a public company.

What is DNTH103?

DNTH103 is a potential therapeutic designed by Dianthus Therapeutics aimed at treating severe neuromuscular conditions, currently in Phase 2 trials.

What is the focus of Dianthus Therapeutics?

Dianthus focuses on developing advanced antibody therapies to address severe autoimmune and inflammatory diseases.

How can I learn more about Dianthus Therapeutics?

You can visit their official website at www.dianthustx.com.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Fresh Leadership at Master Group: Langelier Steps In

Updated Category News Views 5

Changing of the Guard: A Calculated Move It's not every day you see a company make a move as calculated and thoughtful as the one the Master Group just pulled. Rémy Langelier is set to transition into the shoes of CEO by early 2027, fresh off the heels of Louis St-Laurent. This isn't just any executive shuffle, folks—it's a strategic baton pass spawning an investment...

Continue Reading
Wisconsin Chefs Transform Pizza with Crave Brothers Cheese

Updated Category News Views 4

Reimagining Pizza with Wisconsin's Best Cheeses It's not every day you see a pizza challenge that turns a staple of Friday nights into a gastronomic showcase. But that's exactly what's happening in Wisconsin as chefs flex their creativity using Crave Brothers Farmstead Cheese. This is no ordinary cheese-and-pepperoni affair—these culinary pros are cooking up pizzas with...

Continue Reading
Maternal Health Index: A New Tool With Big Ambitions

Updated Category News Views 8

A Fresh Take on Maternal Health Today's all about the Heartland Forward's fresh tool, the Maternal Resiliency Index. It's making a splash at the 2026 Heartland Summit with a lot of promise on its shoulders. Backed by economists and health gurus like Emily Oster and Dr. Neel Shah, this index ain't your run-of-the-mill tool. It's here to shake the couch coins out of...

Continue Reading
Mitsubishi's Q3 Sales: SUVs Up, Mirage Out

Updated Category News Views 4

You ever notice how the market treats innovation and tradition like they’re these ever-spinning plates in a circus act? Take Mitsubishi Motors North America (MMNA). Their third-quarter report's got me both nodding in approval and scratching my head. Sure, they sold 18,543 vehicles—down 5.6% from the previous year. But don’t write 'em off just yet. The slumping...

Continue Reading
Rochester Memorial Installations: Key Timelines Revealed

Updated Category News Views 6

There are times in life where patience isn’t just a virtue, it’s a necessity—memorial installations are one of those instances. In Rochester, NY, folks dealing with the loss of a loved one want more than just closures; they want to commemorate their people in a way that lasts. But how long does it take, really, to set these tributes in stone? Understanding the...

Continue Reading
New Tools Arm Manufacturers in Additive Arena

Updated Category News Views 3

Diving Headfirst into Additive Manufacturing Standards Additive manufacturing (AM)—it's not just another tech buzzword. It's revolutionizing everything from life-saving medical devices to cutting-edge aerospace components. But as with any game-changing innovation, there's a wild west era before standards reign in the chaos. Enter ANSI and America Makes, offering new...

Continue Reading
Quorum Joins LIVE Coalition to Revolutionize Estate Planning

Updated Category News Views 5

Shaking Up Estate Planning: Quorum Joins LIVE Coalition Here's a fresh shake-up in the world of estate planning. Quorum Federal Credit Union has thrown its hat into the ring as the latest member of the LIVE Coalition, a band of financial, legal, and tech wizards putting estate plans on a modern track. This marks them as the 70th player to dive into this alliance, pushing...

Continue Reading
Cannatrol and Veterans Nonprofit Unite for Healing

Updated Category News Views 5

Veterans Find a New Ally in Cannabis Tech When two distinct worlds collide for a cause, it can create waves of change much bigger than simple collaboration. That's exactly what's happening with Cannatrol and Operation Green Healing, a partnership that could redefine support for our veterans. Cannatrol, renowned for its groundbreaking post-harvest cannabis technology, has...

Continue Reading
Varda Space's Dual Launch Signals Orbital Ambitions

Updated Category News Views 7

It's not every day you see two commercial rockets heading to orbit on the same ride, but that's precisely what Varda Space Industries just pulled off. With the W-8 and W-9 vehicles blasting off together, Varda is positioning itself for a leap in orbital operations. They've hitched a ride aboard SpaceX's Transporter-18 mission, and this is more than just a double...

Continue Reading
Sports Research Joins Costco: Creatine Mix Available

Updated Category News Views 5

Breaking Into the Big League: Sports Research Hits Costco When a company's product finds its way onto Costco's shelves, you know they're not just playing in the minor leagues anymore. This October, Sports Research® made a bold move into the retail giant's sports nutrition section with their new Creatine + Electrolytes powder. It's not their first rodeo when it comes to...

Continue Reading

Top 5 Most Recently Viewed Articles

Investigation of Hub Group, Inc. Securities Claims Underway

Updated Category News Views 147

Rosen Law Firm Conducts Investigation for Hub Group, Inc. Investors The Rosen Law Firm, renowned for championing investor rights, has embarked on a significant inquiry focused on Hub Group, Inc. (NASDAQ: HUBG). The investigation centers around potential securities claims impacting shareholders, particularly concerning claims of potentially misleading business...

Continue Reading
PaleBlueDot AI Secures $255M: Expanding AI Horizons

Updated Category News Views 16

When AI Ambitions Meet Big Money PaleBlueDot AI, a shiny new face from Silicon Valley, has bagged a hefty US$255 million credit refinancing package, marking a significant move in the highly competitive AI sector. Now, if you're scribbling numbers on the back of your kid's math homework, you're thinking: now that's a chunk of change. We're talking serious dough to reinvest...

Continue Reading
Innovative Trends Driving Powertrain Technologies Growth Ahead

Updated Category News Views 332

The Future of Powertrain Technologies: A Market Transformation Story In the global automotive landscape, a major revolution is underway, shifting the focus from traditional fuels to innovations such as electric, hydrogen, and hybrid alternatives. The powertrain, which is fundamental to vehicle propulsion, is experiencing a metamorphosis like never before. As...

Continue Reading
CEO's Significant Stock Purchase Signals Confidence in PROS Holdings

Updated Category News Views 69

CEO's Significant Stock Purchase Reflects Confidence in PROS Holdings Andres Reiner, the President and CEO of PROS Holdings, Inc. (NYSE: PRO), has recently made a noteworthy investment in the company's future by purchasing a significant amount of its stock. As reported in a recent filing with the Securities and Exchange Commission (SEC), Reiner bought 7,500 shares of PROS...

Continue Reading
Exploring the Future of the Peripheral Spondyloarthritis Market

Updated Category News Views 249

Overview of the Peripheral Spondyloarthritis Market The peripheral spondyloarthritis market is poised for substantial growth, with projections indicating that it will escalate to a valuation of approximately US$ 5,220.7 million. This marks a remarkable Compound Annual Growth Rate (CAGR) of 6.8% between the years 2024 and 2034. A pivotal factor fueling this growth is the...

Continue Reading